医学
肿瘤坏死因子α
内科学
癌胚抗原
白细胞介素
腺癌
胰腺导管腺癌
促炎细胞因子
胰腺癌
肿瘤科
胃肠病学
免疫学
细胞因子
炎症
癌症
作者
Simona Dima,Cristiana Tănase,Radu Albulescu,Vlad Herlea,Mihaela Chivu‐Economescu,Raluca Purnichescu‐Purtan,Traian Dumitraşcu,Dan Gabriel Duda,Irinel Popescu
出处
期刊:Pancreas
[Lippincott Williams & Wilkins]
日期:2012-06-01
卷期号:41 (7): 1001-1007
被引量:88
标识
DOI:10.1097/mpa.0b013e3182546e13
摘要
OBJECTIVES: We measured the serum concentration of a panel of inflammatory cytokines and evaluated their association with circulating proangiogenic biomarkers and with outcome in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: We collected serum samples from 36 patients with PDAC, 9 patients with chronic pancreatitis, and 22 healthy volunteers as a control. Inflammatory cytokines and proangiogenic biomarkers were measured using the multianalyte xMAP array and carcinoembryonic antigen (CEA) and carbohydrate 19-9 by immunoassay. RESULTS: Patients with PDAC had higher circulating levels of interleukin 6 (IL-6) than those of patients with pancreatitis or healthy individuals and higher levels of IL-10 and tumor necrosis factor α (TNF-α) compared with those of healthy individuals. In patients with PDAC, circulating IL-6, TNF-α, IL-1β, and IL-10 correlated with serum concentrations of vascular endothelial growth factor and basic fibroblast growth factor; circulating IL-6, IL-1β, and TNF-α correlated with carbohydrate 19-9; and IL-8, IL-10, and TNF-α correlated with CEA levels. Circulating IL-8, TNF-α, and CEA; tumor stage; and lymph node metastases were associated with a poor outcome. CONCLUSIONS: The results of this exploratory study indicate that inflammatory cytokines should be pursued as potential prognostic biomarkers as well as targets for therapy in larger studies in PDAC.
科研通智能强力驱动
Strongly Powered by AbleSci AI